Polaris Capital Management, LLC

Position in GILD — Gilead Sciences, Inc.

CIK 1316926 BOSTON, MA

Position in GILD

as of Jun 30, 2026 · filed Jul 27, 2026 Compact

Position Value

$19,367,922

-$15,781,192 QoQ

Shares Held

153,300

-39.2% QoQ

Ownership

0.012%

of shares outstanding

% of Portfolio

1.86%

of 13F equity value

Holder Rank

#328

of 2,266 holders

Holding Since

Sep 2022

16 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Polaris Capital Management, LLC holds $37,300,794 across 2 Drug Manufacturers - General names. GILD ranks #1 (51.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)	Open
1	GILD	Gilead Sciences, Inc. This page	153,300	$19,367,922
2	ABBV	AbbVie Inc.	71,264	$17,932,872

16 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$19,367,922	153,300	-39.2%	Shares	Sole	2026-07-27
2026-03-31	$35,149,114	252,200	-4.9%	Shares	Sole	2026-04-27
2025-12-31	$32,538,374	265,100	-15.1%	Shares	Sole	2026-01-29
2025-09-30	$34,676,400	312,400	-3.8%	Shares	Sole	2025-10-27
2025-06-30	$36,021,663	324,900	-9.7%	Shares	Sole	2025-07-21
2025-03-31	$40,304,385	359,700	-13.9%	Shares	Sole	2025-05-14
2024-12-31	$38,573,712	417,600	-2.5%	Shares	Sole	2025-01-29
2024-09-30	$35,908,672	428,300	+1.5%	Shares	Sole	2024-11-13
2024-06-30	$28,946,559	421,900	+7.3%	Shares	Sole	2024-07-26
2024-03-31	$28,801,900	393,200	-9.8%	Shares	Sole	2024-04-24
2023-12-31	$35,296,057	435,700	-2.5%	Shares	Sole	2024-02-07
2023-09-30	$33,483,192	446,800	-30.4%	Shares	Sole	2023-10-30
2023-06-30	$49,440,405	641,500	-3.0%	Shares	Sole	2023-07-31
2023-03-31	$54,851,467	661,100	-0.0%	Shares	Sole	2023-05-03
2022-12-31	$56,781,190	661,400	+1.5%	Shares	Sole	2023-02-09
2022-09-30	$40,209,542	651,800	—	Shares	Sole	2022-11-10
No filing history on record for this holder in this stock.